Huntington's disease is a hereditary disease with autosomal dominant t
ransmission which generally occurs in adults. The gene was discovered
in 1983 and the genetic abnormality in March 1993. The most commonly r
ecognized clinical manifestation is choreiform movements although othe
r signs often appear more invalidating to family and friends. Cognitiv
e decline, modifications in behaviour, and sometimes psychiatric distu
rbances are perceived as the major handicap in everyday life, In this
review, emphasis has been placed on late onset forms of the disease. R
ecent research has focused on morphologic and functional imagery, the
neuropathologic stages of selective neurone loss beginning in the stri
atum, and the role of excitotoxic amino-acids. Certain ethical conside
rations must be addressed when determining prognosis. Predictive tests
and follow up must be prepared and conducted scrupulously and propose
d to voluntary, informed, major subjects at risk. Tests should be perf
ormed by a qualified laboratory working on anonymous samples, independ
ent of the clinical team, and should be given to the subject orally by
a genetic counsellor. A prenatal test may be requested by parents at
risk. The question of treatment, which to date can only offer symptoma
tic relief, should be re-addressed in light of the recent discovery of
the mutation published in March 1993.